AI Article Synopsis
- The study aimed to investigate whether combining ridostin and tamiflu could enhance treatment and prophylaxis effects in mice infected with a dangerous strain of influenza (H5N1).
- Mice were infected and treated in various ways (with either drug or both together) and were monitored for 16 days, focusing on survival rates, virus levels, and overall health.
- The results showed that using both drugs together after infection improved survival rates and reduced virus levels in the lungs compared to the control group.
Article Abstract
Aim: Study of possibility of treatment-prophylaxis effect increase during combined administration of ridostin and tamiflu in experiments in mice infected with highly pathogenic influenza virus strain A/chicken/Kurgan/05/2005 (H5N1).
Materials And Methods: Balb/c line mice infected intranasally with influenza virus at 100 and 10 LD50 doses received ridostin and tamiflu as monopreparation or the combined variant before or after the infection. The mice were observed for 16 days, lethality rate, protection coefficient and average life span were evaluated. Virus concentration in lungs was determined by using titration in MDCK cell line.
Results: Combined administration ofridostin and tamiflu after the infection increased survivability of the animals when compared with the control group, and reduced influenza virus concentration in lungs.
Conclusion: Treatment effect during combined administration of ridostin and tamiflu after influenza virus infection increased.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!